Pub Date : 2023-08-01DOI: 10.1089/genbio.2023.0036
M. A. Mahmood, Shahida Mansoor
{"title":"A Prime Example of Dual Deception","authors":"M. A. Mahmood, Shahida Mansoor","doi":"10.1089/genbio.2023.0036","DOIUrl":"https://doi.org/10.1089/genbio.2023.0036","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47637369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1089/genbio.2023.29110.gsw
GEN BiotechnologyVol. 2, No. 4 News FeaturesFree AccessFanzor: First CRISPR-Like System Found in EukaryotesGEN Staff WriterGEN Staff WriterPublished Online:17 Aug 2023https://doi.org/10.1089/genbio.2023.29110.gswAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Feng Zhang's team at the Broad Institute discovers RNA-guided Fanzor enzymes from fungi and amoeba that show promise for genome editing applications.A cryo-EM map of a Fanzor protein (gray, yellow, light blue, and pink) in complex with ωRNA (purple) and its target DNA (red). Non-target DNA strand in blue.(Credit: Zhang lab, Broad Institute of MIT and Harvard/McGovern Institute for Brain Research at MIT).Another potentially game-changing discovery in the world of genome editing has come out of the Broad Institute lab of Feng Zhang. In a study published in Nature, Zhang and colleagues have uncovered the first programmable RNA-guided system in eukaryotes.1 Earlier this year, the Zhang lab adapted a contractile injection system, found naturally in bacteria, that delivers protein payloads to target human cells.2In the latest study, Zhang's team describes how the eukaryotic system—based on the Fanzor protein—uses RNA as a guide to target DNA precisely and shows that Fanzor can be reprogrammed to edit the genome of human cells. In addition, the compact Fanzor systems have the potential to be more easily delivered to cells and tissues as therapeutics than CRISPR-Cas systems. Further refinements to improve their targeting efficiency could make them a valuable new technology for human genome editing.Scientists have long wondered whether systems similar to the well-known bacterial CRISPR system exist in eukaryotes. In a recent analysis published in The CRISPR Journal (a sister journal to GEN Biotechnology), Blake Wiedenheft's group at Montana State University studied repetitive elements that had previously been identified as putative CRISPR loci in the human genome. They showed that these repeats do not contain the repeat-spacer-repeat architecture nor the cas nuclease genes characteristic of functional CRISPR systems.3“Overall, the evidence for functional CRISPR-Cas systems in the human genome and other eukaryotic genomes remains unsupported,” the authors wrote. “Although the phylogenetic and functional diversity of CRISPRs continue to expand, (to date) CRISPR-Cas adaptive immune systems remain restricted to prokaryotes.”3Present and CorrectNevertheless, the new Zhang lab study demonstrates that RNA-guided DNA-cutting mechanisms are present across all kingdoms of life.“CRISPR-based systems are widely used and powerful because they can be easily reprogrammed to target different sites in the genome,” said Zhang, a core institute member at the Broad Institute. “This new system is another way to make precise changes in human cells, complementing the genome editing tools we already
创BiotechnologyVol。2、No. 4新闻专题免费访问在真核生物中发现的第一个crispr样系统发表在网上:2023年8月17日https://doi.org/10.1089/genbio.2023.29110.gswAboutSectionsPDF/EPUB权限和引文下载引文添加到收藏返回出版分享分享在facebook上推特链接在redditemail张锋的团队在Broad研究所发现真菌和变形虫的rna引导的Fanzor酶,显示出基因组编辑应用的希望。Fanzor蛋白(灰色,黄色,浅蓝色和粉红色)与ωRNA(紫色)及其目标DNA(红色)的复合物的冷冻电镜图。蓝色的是非目标DNA链。(来源:张实验室、麻省理工学院博德研究所和哈佛/麦戈文麻省理工学院大脑研究所)。在基因组编辑领域,另一个可能改变游戏规则的发现来自博德研究所张锋的实验室。在《自然》杂志上发表的一项研究中,张和他的同事发现了真核生物中第一个可编程rna引导系统今年早些时候,张教授的实验室采用了一种天然存在于细菌中的可收缩注射系统,该系统可将蛋白质有效载荷传递给目标人体细胞。在最新的研究中,Zhang的团队描述了基于Fanzor蛋白的真核生物系统如何使用RNA作为精确靶向DNA的指南,并表明Fanzor可以被重新编程以编辑人类细胞的基因组。此外,紧凑的Fanzor系统比CRISPR-Cas系统更容易作为治疗药物输送到细胞和组织中。进一步改进它们的靶向效率可能使它们成为人类基因组编辑的一项有价值的新技术。长期以来,科学家们一直想知道真核生物中是否存在类似于众所周知的细菌CRISPR系统的系统。在最近发表在《CRISPR杂志》(《GEN生物技术》的姊妹杂志)上的一篇分析文章中,蒙大拿州立大学的Blake Wiedenheft团队研究了先前被认为是人类基因组中CRISPR基因座的重复元素。他们发现,这些重复序列不包含重复-间隔-重复结构,也不包含功能性CRISPR系统所特有的cas核酸酶基因。作者写道:“总的来说,人类基因组和其他真核生物基因组中功能性CRISPR-Cas系统的证据仍然没有得到支持。”“尽管crispr的系统发育和功能多样性继续扩大,(迄今为止)CRISPR-Cas适应性免疫系统仍然局限于原核生物。然而,Zhang实验室的新研究表明,rna引导的dna切割机制存在于所有生命领域。“基于crispr的系统被广泛使用和强大,因为它们可以很容易地重新编程,以针对基因组中的不同位点,”博德研究所的核心研究所成员张说。“这个新系统是对人类细胞进行精确改变的另一种方式,是对我们已经拥有的基因组编辑工具的补充。”十年前,2013年1月,张和他的前导师乔治·丘奇(George Church)首次独立展示了细菌CRISPR-Cas9编辑系统在真核细胞中的作用。张教授实验室的一个主要目标是利用能够通过靶向特定基因和过程来调节人类细胞的系统来开发基因药物。“几年前,我们开始问,‘除了CRISPR之外还有什么,自然界中还有其他rna可编程系统吗?’”张回忆道。两年前,张教授的实验室成员在原核生物中发现了一类被称为OMEGAs的rna可编程系统,这种系统通常与细菌基因组中的转座因子相关联,并可能产生CRISPR-Cas系统。该研究还强调了真核生物中原核OMEGA系统和Fanzor蛋白之间的相似性,表明Fanzor酶也可能使用rna引导机制靶向和切割DNA。在最新的研究中,研究人员通过从真菌、藻类和变形虫物种中分离出Fanzor来继续他们对rna引导系统的研究。Fanzor蛋白的生化特性表明,它们是dna切割内切酶,利用附近的非编码rna (γ rna)靶向基因组中的特定位点。这是首次在真核生物中发现这种机制。与CRISPR蛋白不同,Fanzor酶是在真核生物基因组的转座元件中编码的。Zhang团队的系统发育分析表明,Fanzor基因是通过水平基因转移从细菌迁移到真核生物的。研究人员随后证明,Fanzor可以在人类细胞内的目标基因组位点上产生插入和缺失。他们发现,Fanzor系统最初在剪切DNA方面的效率低于CRISPR-Cas系统,但通过基因工程将蛋白质的活性提高了10倍。 此外,与一些CRISPR系统和OMEGA蛋白TnpB不同,Zhang的研究小组发现,真菌衍生的Fanzor蛋白没有表现出“附带活性”,即RNA引导酶切割其DNA靶标并降解附近的DNA或RNA。结果表明,Fanzor可能被开发为高效的基因组编辑器。该小组还分析了Fanzor/ωRNA复合物的分子结构。他们发现,Fanzor与CRISPR-Cas12具有结构相似性,但ωRNA与Fanzor催化结构域之间的相互作用更为广泛,这表明ωRNA可能在催化反应中发挥作用。与基于crispr的系统类似,Fanzor系统可以很容易地重新编程以靶向特定的基因组位点。张说,有一天它可能会发展成为一种强大的新的基因组编辑技术,用于研究和治疗应用。大量rna引导的内切酶,如Fanzor,进一步扩大了已知的OMEGA系统的数量,并表明还有更多的系统有待发现。“大自然太神奇了。有这么多的多样性!张说。“可能还有更多的rna可编程系统,我们将继续探索,并有望发现更多。”参考文献1。Saito M,徐平,Faure G,等。Fanzor是一种真核生物可编程rna引导的内切酶。自然2023;doi: 10.1038/s41586-023-06356-2 Google Scholar2。大自然的针头:将细菌“注射器”改造成可编程的蛋白质输送装置。生物工程学报(英文版);2023;2:162-166;doi: 10.1089 / genbio.2023.29098。jdg Link, Google Scholar3。buyukyyoruk M, Henriques WS, Wiedenheft B.阐明CRISPR:为什么在人类基因组中识别的重复序列不应该被认为是CRISPR。Crispr . j [j]; 2009; 6:216-221;doi: 10.1089/crispr.2022.0106 Link, Google ScholarFiguresReferencesRelatedDetails Volume 2Issue 4Aug 2023信息版权所有,Mary Ann Liebert, Inc., publisher .本文引用:GEN特约撰稿人。Fanzor:在真核生物中发现的第一个crispr样系统。创生物技术。2023.8月276-277.http://doi.org/10.1089/genbio.2023.29110.gswPublished vol: 2 Issue 4: 2023年8月17日pdf下载
{"title":"Fanzor: First CRISPR-Like System Found in Eukaryotes","authors":"","doi":"10.1089/genbio.2023.29110.gsw","DOIUrl":"https://doi.org/10.1089/genbio.2023.29110.gsw","url":null,"abstract":"GEN BiotechnologyVol. 2, No. 4 News FeaturesFree AccessFanzor: First CRISPR-Like System Found in EukaryotesGEN Staff WriterGEN Staff WriterPublished Online:17 Aug 2023https://doi.org/10.1089/genbio.2023.29110.gswAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail Feng Zhang's team at the Broad Institute discovers RNA-guided Fanzor enzymes from fungi and amoeba that show promise for genome editing applications.A cryo-EM map of a Fanzor protein (gray, yellow, light blue, and pink) in complex with ωRNA (purple) and its target DNA (red). Non-target DNA strand in blue.(Credit: Zhang lab, Broad Institute of MIT and Harvard/McGovern Institute for Brain Research at MIT).Another potentially game-changing discovery in the world of genome editing has come out of the Broad Institute lab of Feng Zhang. In a study published in Nature, Zhang and colleagues have uncovered the first programmable RNA-guided system in eukaryotes.1 Earlier this year, the Zhang lab adapted a contractile injection system, found naturally in bacteria, that delivers protein payloads to target human cells.2In the latest study, Zhang's team describes how the eukaryotic system—based on the Fanzor protein—uses RNA as a guide to target DNA precisely and shows that Fanzor can be reprogrammed to edit the genome of human cells. In addition, the compact Fanzor systems have the potential to be more easily delivered to cells and tissues as therapeutics than CRISPR-Cas systems. Further refinements to improve their targeting efficiency could make them a valuable new technology for human genome editing.Scientists have long wondered whether systems similar to the well-known bacterial CRISPR system exist in eukaryotes. In a recent analysis published in The CRISPR Journal (a sister journal to GEN Biotechnology), Blake Wiedenheft's group at Montana State University studied repetitive elements that had previously been identified as putative CRISPR loci in the human genome. They showed that these repeats do not contain the repeat-spacer-repeat architecture nor the cas nuclease genes characteristic of functional CRISPR systems.3“Overall, the evidence for functional CRISPR-Cas systems in the human genome and other eukaryotic genomes remains unsupported,” the authors wrote. “Although the phylogenetic and functional diversity of CRISPRs continue to expand, (to date) CRISPR-Cas adaptive immune systems remain restricted to prokaryotes.”3Present and CorrectNevertheless, the new Zhang lab study demonstrates that RNA-guided DNA-cutting mechanisms are present across all kingdoms of life.“CRISPR-based systems are widely used and powerful because they can be easily reprogrammed to target different sites in the genome,” said Zhang, a core institute member at the Broad Institute. “This new system is another way to make precise changes in human cells, complementing the genome editing tools we already","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136221685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1089/genbio.2023.0022
Duverney Chaverra-Rodriguez, Michelle Bui, Cody L. Gilleland, Jason L. Rasgon, Omar S. Akbari
The most devastating disease affecting the global citrus industry is Huanglongbing (HLB), caused by the pathogen Candidatus Liberibacter asiaticus. HLB is primarily spread by the insect vector Diaphorina citri (Asian Citrus Psyllid). To counteract the rapid spread of HLB by D. citri, traditional vector control strategies such as insecticide sprays, the release of natural predators, and mass introductions of natural parasitoids are used. However, these methods alone have not managed to contain the spread of disease. To further expand the available tools for D. citri control through generating specific modifications of the D. citri genome, we have developed protocols for CRISPR-Cas9-based genetic modification. Until now, genome editing in D. citri has been challenging due to the general fragility and size of D. citri eggs. Here we present optimized methods for collecting and preparing eggs to introduce the Cas9 ribonucleoprotein (RNP) into early embryos and alternative methods of injecting RNP into the hemocoel of adult females for ovarian transduction. Using these methods, we have generated visible somatic mutations, indicating their suitability for gene editing in D. citri. These methods represent the first steps toward advancing D. citri research in preparation for future genetic-based systems for controlling HLB.
{"title":"CRISPR-Cas9-Mediated Mutagenesis of the Asian Citrus Psyllid, <i>Diaphorina citri</i>","authors":"Duverney Chaverra-Rodriguez, Michelle Bui, Cody L. Gilleland, Jason L. Rasgon, Omar S. Akbari","doi":"10.1089/genbio.2023.0022","DOIUrl":"https://doi.org/10.1089/genbio.2023.0022","url":null,"abstract":"The most devastating disease affecting the global citrus industry is Huanglongbing (HLB), caused by the pathogen Candidatus Liberibacter asiaticus. HLB is primarily spread by the insect vector Diaphorina citri (Asian Citrus Psyllid). To counteract the rapid spread of HLB by D. citri, traditional vector control strategies such as insecticide sprays, the release of natural predators, and mass introductions of natural parasitoids are used. However, these methods alone have not managed to contain the spread of disease. To further expand the available tools for D. citri control through generating specific modifications of the D. citri genome, we have developed protocols for CRISPR-Cas9-based genetic modification. Until now, genome editing in D. citri has been challenging due to the general fragility and size of D. citri eggs. Here we present optimized methods for collecting and preparing eggs to introduce the Cas9 ribonucleoprotein (RNP) into early embryos and alternative methods of injecting RNP into the hemocoel of adult females for ovarian transduction. Using these methods, we have generated visible somatic mutations, indicating their suitability for gene editing in D. citri. These methods represent the first steps toward advancing D. citri research in preparation for future genetic-based systems for controlling HLB.","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136221684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1089/genbio.2023.29112.sro
Sachin Rawat
{"title":"Creating Self-Organizing Systems with Synthetic Multicellularity","authors":"Sachin Rawat","doi":"10.1089/genbio.2023.29112.sro","DOIUrl":"https://doi.org/10.1089/genbio.2023.29112.sro","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"61126931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1089/genbio.2023.29104.rki
Rachel King, A. Philippidis
{"title":"From the Boardroom to BIO: An Interview with Rachel King","authors":"Rachel King, A. Philippidis","doi":"10.1089/genbio.2023.29104.rki","DOIUrl":"https://doi.org/10.1089/genbio.2023.29104.rki","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41598638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-01DOI: 10.1089/genbio.2023.29106.bta
Bo Tao, Hongyuan Yang, Rong Fan
{"title":"Seeing the Action of Lipid Droplets in Aging and Longevity","authors":"Bo Tao, Hongyuan Yang, Rong Fan","doi":"10.1089/genbio.2023.29106.bta","DOIUrl":"https://doi.org/10.1089/genbio.2023.29106.bta","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46019186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1089/genbio.2023.29097.editorial
Hana El-Samad
{"title":"The Potential of Public–Private Partnerships for the Bioeconomy","authors":"Hana El-Samad","doi":"10.1089/genbio.2023.29097.editorial","DOIUrl":"https://doi.org/10.1089/genbio.2023.29097.editorial","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48178931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1089/genbio.2023.0026
P. Russmeyer
{"title":"Breaking the Chains of Health Data","authors":"P. Russmeyer","doi":"10.1089/genbio.2023.0026","DOIUrl":"https://doi.org/10.1089/genbio.2023.0026","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41452753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-06-01DOI: 10.1089/genbio.2023.29099.muh
M. Uhlén, Fay Lin
{"title":"Antibody There? Mapping the Human Proteome with Mathias Uhlén","authors":"M. Uhlén, Fay Lin","doi":"10.1089/genbio.2023.29099.muh","DOIUrl":"https://doi.org/10.1089/genbio.2023.29099.muh","url":null,"abstract":"","PeriodicalId":73134,"journal":{"name":"GEN biotechnology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45216065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}